Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-16T17:59:42.120Z Has data issue: false hasContentIssue false
  • English
  • Français

Responses of Growth Hormone to Desipramine in Endogenous and Non-endogenous Depression

Published online by Cambridge University Press:  02 January 2018

Timothy G. Dinan  and
Siobhan Barry
Timothy G. Dinan*
Affiliation:
Department of Psychiatry, Trinity College Medical School, St James's Hospital, Dublin 8, Ireland
Siobhan Barry
Affiliation:
Department of Psychiatry, Trinity College Medical School, St James's Hospital, Dublin 8, Ireland
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

Desipramine, a monoamine reuptake inhibitor, was used to stimulate release of growth hormone (GH) in 29 DSM-III major depressives and in 10 healthy controls. Eighteen of the depressives showed a blunted response. The GH-stimulation test was unable to distinguish endogenous from non-endogenous patients. The 13 dexamethasone non-suppressors were more likely to have a blunted GH response than the 14 suppressors. The results indicate that at least a subset of non-endogenous depressives have significant neuroendocrine abnormality.

Type
Lecture
Information
The British Journal of Psychiatry , Volume 156 , Issue 5 , May 1990 , pp. 680 - 684
Copyright
Copyright © Royal College of Psychiatrists, 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.Google Scholar
Ansseau, M., Von Frenckell, R., Cerfontaine, J. L., et al (1988) Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. British Journal of Psychiatry, 153, 65–71.Google Scholar
Calil, H. M., Lesieur, P., Gold, P. W., et al (1984) Hormonal responses to zimelidine and desipramine in depressed patients. Psychiatry Research, 13, 231–242.Google Scholar
Carney, M. W. P., Roth, M. & Garside, R. F. (1965) The diagnosis of depressive syndromes and the prediction of ECT response. British Journal of Psychiatry, 111, 659–674.CrossRefGoogle Scholar
Carroll, B. J. (1982) The dexamethasone suppression test for melancholia. British Journal of Psychiatry, 140, 292–304.CrossRefGoogle ScholarPubMed
Charney, D. S., Heninger, G. R., Steinberg, D. E., et al (1982) Adrenergic receptor sensitivity in depression: effects of clonidine in depressed patients and healthy controls. Archives of General Psychiatry, 39, 290–294.Google Scholar
Checkley, S. A., Slade, A. P. & Shur, P. (1981) Growth hormone and other responses to clonidine in patients with endogenous depression. British Journal of Psychiatry, 138, 51–55.Google Scholar
Checkley, S. A., Glass, I. B., Thompson, C., et al (1984) The growth hormone response to clonidine in endogenous as compared to reactive depression. Psychological Medicine, 14, 773–774.Google Scholar
Checkley, S. A., Corn, T. H., Glass, I. B., et al (1986) The responsiveness of central alpha-2 adrenoceptors in depression. In The Biology of Depression (ed. Deakin, J. F. W.). London: Gaskell.Google Scholar
Corn, T. H., Thompson, C. & Checkley, S. A. (1984) Effects of desipramine treatment upon central adrenoceptor function in normal subjects. British Journal of Psychiatry, 145, 139–145.Google Scholar
Dolan, R. J. & Calloway, S. P. (1986) The human growth hormone response to clonidine: relationship to clinical and neuroendocrine profile in depression. American Journal of Psychiatry, 143, 772–774.Google ScholarPubMed
Glass, I. B., Checkley, S. A., Shur, E., et al (1982) The effect of desipramine upon central adrenergic function in depressed patients. British Journal of Psychiatry, 141, 372–376.Google Scholar
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–296.CrossRefGoogle ScholarPubMed
Holden, H. L. (1983) Depression and the Newcastle Scale. Their relationship to the dexamethasone suppression test. British Journal of Psychiatry, 142, 505–507.Google Scholar
Katakami, H., Kato, Y., Matsushita, N., et al (1984) Effects of neonatal treatment with monosodium glutamate on growth hormone release induced by clonidine and prostaglandin E1 in conscious male rats. Neuroendocrinology, 38, 1–5.CrossRefGoogle ScholarPubMed
Katona, C. L. E., Theodorou, A. E., Davies, S. L., et al (1986) Platelet binding and neuroendocrine responses in depression. In The Biology of Depression (ed. Deakin, J. F. W.). London: Gaskell.Google Scholar
Laakmann, G. (1980) Beinflussung der Hypophysenvorderlappen – Hormonsekretion durch Antidepressive bei gesunden Probanden, neurotisch und endogen depressiven Patienten. Der Nervenarzt, 51, 725–732.Google Scholar
Laakmann, G., Schumacher, G., Benkert, O., et al (1977) Stimulation of growth hormone secretion by desipramine and chlorimipramine in man. Journal of Clinical Endocrinology and Metabolism, 44, 1010–1013.Google Scholar
Laakmann, G., Zygan, K., Schoen, H. W., et al (1986) Effect of receptor blockers (methylsergide, propranolol, phentolamine, yohimbine and prazosin) on desipramine-induced pituitary hormone stimulation in humans – 1. Growth hormone. Psychoneuroendocrinology, 11, 447–461.CrossRefGoogle Scholar
Lovinger, R., Holland, J., Kaplan, S., et al (1976) Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs. Neuroscience, 1, 443–450.Google Scholar
Maas, J. W. (1975) Biogenic amines and depression. Archives of General Psychiatry, 3, 1357–1361.Google Scholar
Matussek, N., Ackenhail, M., Hippius, H., et al (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Research, 2, 25–36.Google Scholar
Meesters, P., Kerhofs, M., Charles, G., et al (1985) Growth hormone release after desipramine in depressive illness. European Archives of Psychiatric and Neurological Science, 235, 140–142.CrossRefGoogle ScholarPubMed
Salvatore Raite (1983) The standards of human growth hormone assays. In Evaluation of Growth Hormone Secretion (eds Laron, Z. & Butenandt, O.). Basel: Karger.Google Scholar
Sawa, Y., Odo, S. & Nakasawa, T. (1981) Growth hormone secretion by tricyclic and non-tricyclic antidepressants in normal volunteers and depressives. Abstracts of the Third World Congress of Biological Psychiatry, 2, F428.Google Scholar
Sawa, Y. & Odo, S. (1982) Growth hormone secretion by tricyclic and non-tricyclic antidepressants in healthy volunteers and depressives. In New Vistas in Depression (eds Langer, S. Z., Takahashi, R., Segawa, T., et al). New York: Pergamon.Google Scholar
Siever, L. J., Uhde, T. W., Silberman, E. K., et al (1982) The growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Research, 6, 171–183.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.